Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
16.12
-0.02 (-0.12%)
Nov 21, 2024, 4:00 PM EST - Market closed
Pulse Biosciences Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Pulse Biosciences.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for PLSE.
Recommendation Trends
Rating | Apr '22 | May '22 | Jun '22 | Jul '22 | Aug '22 | Sep '22 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Hold | 0 | 1 | 1 | 1 | 1 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 21, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 13, 2022 |
Stephens & Co. | Stephens & Co. | Buy Maintains $14 → $12 | Buy | Maintains | $14 → $12 | -25.56% | Apr 1, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $8.5 | Strong Buy | Maintains | $20 → $8.5 | -47.27% | Apr 1, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $43 → $20 | Strong Buy | Maintains | $43 → $20 | +24.07% | Feb 10, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.92
from -0.88
EPS Next Year
n/a
from -0.92
Revenue Forecast
Revenue | 2024 |
---|---|
High | n/a |
Avg | n/a |
Low | n/a |
Revenue Growth
Revenue Growth | 2024 |
---|---|
High | - |
Avg | - |
Low | - |
EPS Forecast
EPS | 2024 |
---|---|
High | -0.95 |
Avg | -0.92 |
Low | -0.88 |
EPS Growth
EPS Growth | 2024 |
---|---|
High | - |
Avg | - |
Low | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.